← Back to Search

CBTI plus taper method A for Insomnia (SWITCH Trial)

N/A
Waitlist Available
Led By Constance H Fung, MD MSHS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months after end of treatment
Awards & highlights

SWITCH Trial Summary

This trial is testing a new way to help people stop taking sleeping medications, which can help improve their sleep and overall health.

SWITCH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months after end of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months after end of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hypnotic discontinuation
Insomnia Severity Index score

SWITCH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CBTI plus Taper method AExperimental Treatment1 Intervention
Participants in this arm will receive CBTI plus the novel hypnotic tapering method.
Group II: CBTI plus Taper method BActive Control1 Intervention
Participants in this arm will receive CBTI plus the usual tapering method used by the VA.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CBTI plus taper method A
2018
N/A
~140

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,471 Total Patients Enrolled
26 Trials studying Insomnia
4,065 Patients Enrolled for Insomnia
Constance H Fung, MD MSHSPrincipal InvestigatorVA Greater Los Angeles Healthcare System, West Los Angeles, CA
Constance H Fung, MD MSPrincipal InvestigatorVA Greater Los Angeles Healthcare System, West Los Angeles, CA

Media Library

CBTI plus taper method A Clinical Trial Eligibility Overview. Trial Name: NCT03511209 — N/A
Insomnia Research Study Groups: CBTI plus Taper method A, CBTI plus Taper method B
Insomnia Clinical Trial 2023: CBTI plus taper method A Highlights & Side Effects. Trial Name: NCT03511209 — N/A
CBTI plus taper method A 2023 Treatment Timeline for Medical Study. Trial Name: NCT03511209 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there availability for new participants to join this research?

"At the moment, this clinical trial is not seeking new participants. The first posting was made on December 10th 2018 and its latest update took place on May 6th 2022. However, there are currently 228 other trials actively looking for volunteers."

Answered by AI
Recent research and studies
~21 spots leftby Apr 2025